Varicella Zoster (Shingles) - (Shingrix)

Shingrix® is approved for use for the prevention of herpes zoster (shingles) and herpes zoster complications such as post herpetic neuralgia (PHN) in adults aged over 50 years. PHN is a debilitating and painful condition, particularly in older people. Two doses are funded at age 65 years. It is recommended, but not funded, for all individuals aged from 50 years.

It has been shown to be highly effective with studies >90% in preventing shingles. Response currently last for up to 10 yrs and data still being collected on this and this may extend.


Available for those > 50yrs regardless if prior episode of shingles. If recently had shingles you need to wait 12 months before having the vaccine.

If you have had the Zostavax vaccine (previous shingles vaccine) you can have Shingrix vaccine after 12 months.

Funding and cost:

If 65yrs old can get funded Shingrix, 2 doses 2 to 6 months apart. If first dose given at 65yrs can have 2nd dose at 66yrs. The first dose is the only one needing to be in your 65th year.

If not 65yrs=not funded. $350/dose. Total for course will be $700

More information on the IMAC website

Pop in or call for any frther information or to book an appointment.